- Home
- UTHR vs FTI Comparison
UTHR vs FTI Comparison
Compare UTHR & FTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- FTI
- Stock Information
- Founded
- UTHR 1996
- FTI 1884
- Country
- UTHR United States
- FTI United States
- Employees
- UTHR N/A
- FTI N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- FTI Metal Fabrications
- Sector
- UTHR Health Care
- FTI Industrials
- Exchange
- UTHR Nasdaq
- FTI Nasdaq
- Market Cap
- UTHR 20.7B
- FTI 16.6B
- IPO Year
- UTHR 1999
- FTI N/A
- Fundamental
- Price
- UTHR $446.81
- FTI $42.66
- Analyst Decision
- UTHR Buy
- FTI Strong Buy
- Analyst Count
- UTHR 12
- FTI 11
- Target Price
- UTHR $495.08
- FTI $45.60
- AVG Volume (30 Days)
- UTHR 591.7K
- FTI 4.3M
- Earning Date
- UTHR 10-29-2025
- FTI 10-23-2025
- Dividend Yield
- UTHR N/A
- FTI 0.47%
- EPS Growth
- UTHR 16.08
- FTI 59.09
- EPS
- UTHR 26.38
- FTI 2.28
- Revenue
- UTHR $3,128,400,000.00
- FTI $9,803,000,000.00
- Revenue This Year
- UTHR $13.68
- FTI $10.39
- Revenue Next Year
- UTHR $5.63
- FTI $7.41
- P/E Ratio
- UTHR $17.03
- FTI $18.79
- Revenue Growth
- UTHR 13.50
- FTI 11.44
- 52 Week Low
- UTHR $266.98
- FTI $22.12
- 52 Week High
- UTHR $479.50
- FTI $43.09
- Technical
- Relative Strength Index (RSI)
- UTHR 56.88
- FTI 66.85
- Support Level
- UTHR $430.02
- FTI $41.06
- Resistance Level
- UTHR $456.41
- FTI $43.09
- Average True Range (ATR)
- UTHR 14.19
- FTI 1.34
- MACD
- UTHR 0.19
- FTI 0.34
- Stochastic Oscillator
- UTHR 51.88
- FTI 91.71
About UTHR United Therapeutics Corporation
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
About FTI TechnipFMC plc
TechnipFMC is the largest provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies.